Cigna Group
CIAPI behind this page
CI Q3 2025 request
Playground key active
/api/financials?ticker=CI&year=2025&quarter=3
Pick an endpoint and run the request.Income Statement
| Metric | Q3 2025 | Q3 2024 | YoY |
|---|---|---|---|
| Revenue (Q) | — | — | — |
Show Product Lines breakouts |
|||
| Home delivery and specialty revenues · Evernorth Health Services | 20,513 | 18,909 | +8.5% |
| Network revenues · Evernorth Health Services | 32,525 | 27,353 | +18.9% |
| Other revenues · Evernorth Health Services | 3,403 | 2,990 | +13.8% |
| Product | 56,054 | 48,284 | +16.1% |
| Product · All Other Segments | 14 | 14 | 0.0% |
| Product · Corporate and Eliminations | -401 | -982 | +59.2% |
| Product · Evernorth Health Services | 56,441 | 49,252 | +14.6% |
| Service | 4,380 | 3,889 | +12.6% |
| Service Other | 276 | 267 | +3.4% |
| Service, Fees And Other Revenues [Member] | 4,380 | 3,889 | +12.6% |
| Service, Fees And Other Revenues [Member] · Cigna Healthcare | 1,881 | 1,902 | -1.1% |
| Service, Fees And Other Revenues [Member] · Corporate and Eliminations | -1,422 | -1,377 | -3.3% |
| Service, Fees And Other Revenues [Member] · Evernorth Health Services | 3,921 | 3,345 | +17.2% |
| Premiums Earned Net | 9,081 | 11,436 | -20.6% |
Show Product Lines breakouts |
|||
| Employer insured · Cigna Healthcare | 4,705 | 4,382 | +7.4% |
| Individual and Family Plans · Cigna Healthcare | 788 | 1,001 | -21.3% |
| Other · Cigna Healthcare | 488 | 1,203 | -59.4% |
| Stop loss · Cigna Healthcare | 1,908 | 1,689 | +13.0% |
Show Business Segments breakouts |
|||
| All Other Segments · Operating Segments | 68 | 122 | -44.3% |
| Cigna Healthcare · International Health | 1,047 | 911 | +14.9% |
| Cigna Healthcare · Operating Segments | 8,936 | 11,296 | -20.9% |
| Cigna Healthcare · U.S. Healthcare | 7,889 | 10,385 | -24.0% |
Show Consolidation Items breakouts |
|||
| Corporate and Eliminations | 77 | 18 | +327.8% |
| Net Investment Income | 233 | 85 | +174.1% |
Show Business Segments breakouts |
|||
| All Other Segments · Operating Segments | 80 | 79 | +1.3% |
| Cigna Healthcare · Operating Segments | 116 | 142 | -18.3% |
| Evernorth Health Services · Operating Segments | 29 | -142 | +120.4% |
Show Consolidation Items breakouts |
|||
| Corporate Non Segment | 8 | 6 | +33.3% |
| Revenue | 69,748 | 63,694 | +9.5% |
Show Business Segments breakouts |
|||
| All Other Segments · Operating Segments | 162 | 234 | -30.8% |
| Cigna Healthcare · Operating Segments | 10,933 | 13,340 | -18.0% |
| Evernorth Health Services · Operating Segments | 60,391 | 52,455 | +15.1% |
Show Consolidation Items breakouts |
|||
| Corporate and Eliminations | -1,738 | -2,335 | +25.6% |
| Cost of Revenue | 55,530 | 47,565 | +16.7% |
Show Business Segments breakouts |
|||
| Evernorth Health Services · Operating Segments | 57,326 | 49,768 | +15.2% |
| Policyholder Benefits And Claims Incurred Net | 7,842 | 9,527 | -17.7% |
Show Business Segments breakouts |
|||
| Cigna Healthcare · Operating Segments | 7,579 | 9,355 | -19.0% |
| Selling, General & Administrative | 3,362 | 3,590 | -6.4% |
| Amortization Of Intangible Assets | 436 | 436 | 0.0% |
Show Business Segments breakouts |
|||
| Cigna Healthcare · Operating Segments | 5 | 22 | -77.3% |
| Evernorth Health Services · Operating Segments | 431 | 414 | +4.1% |
| Benefits Losses And Expenses | 67,170 | 61,118 | +9.9% |
| Operating Income | 2,578 | 2,576 | +0.1% |
| Other Non-Operating Income (Expense) | -347 | -376 | +7.7% |
Show Business Segments breakouts |
|||
| Cigna Healthcare · Operating Segments | 2 | 3 | -33.3% |
| Evernorth Health Services · Operating Segments | -2 | — | — |
| Gain Loss On Sale Of Business | 38 | -87 | +143.7% |
| Net Investment Gain Loss | 26 | -921 | +102.8% |
| Income Before Taxes | 2,295 | 1,192 | +92.5% |
Show Business Segments breakouts |
|||
| Cigna Healthcare · Operating Segments | 1,302 | 1,073 | +21.3% |
| Evernorth Health Services · Operating Segments | 1,563 | 631 | +147.7% |
Show Consolidation Items breakouts |
|||
| Corporate Non Segment | -570 | -502 | -13.5% |
| Income Tax Expense (Benefit) | 322 | 367 | -12.3% |
| Net Income | 1,973 | 825 | +139.2% |
Show Equity Components breakouts |
|||
| Noncontrolling Interest | 105 | 86 | +22.1% |
| Parent | 1,868 | 739 | +152.8% |
| Retained Earnings | 1,868 | 739 | +152.8% |
| Net Income Loss Attributable To Noncontrolling Interest | 105 | 86 | +22.1% |
| Net Income Loss Available To Common Stockholders Basic | 1,868 | 739 | +152.8% |
| EPS (Basic) | 7.02 | 2.65 | +164.9% |
| EPS (Diluted) | 6.98 | 2.63 | +165.4% |
| Comprehensive Income | 1,885 | 1,018 | +85.2% |
| Wtd Avg Shares (Diluted) | 267,530 | 281,396 | -4.9% |
Balance Sheet
| Metric | Q3 2025 | Q3 2024 | YoY |
|---|---|---|---|
| Current Assets | |||
| Cash & Cash Equivalents | 6,025 | 5,888 | +2.3% |
| Short-Term Investments | 883 | — | — |
Show Investment Type breakouts |
|||
| Debt Securities | 490 | — | — |
| Equity Securities | 17 | — | — |
| Mortgages | 100 | — | — |
| Short Term Investments | 276 | — | — |
| Receivables Net Current | 31,709 | — | — |
| Inventory | 5,632 | 5,083 | +10.8% |
| Other Assets Current | 2,486 | 2,667 | -6.8% |
| Total Current Assets | 46,735 | 49,222 | -5.1% |
| Reinsurance Recoverables Non Current | 4,207 | 4,557 | -7.7% |
| Non-Current Assets | |||
| Long Term Investments | 18,483 | — | — |
Show Investment Type breakouts |
|||
| Debt Securities | 7,861 | — | — |
| Equity Securities | 3,500 | — | — |
| Mortgages | 1,158 | — | — |
| Other Long Term Investments | 4,884 | — | — |
| Policy Loans | 1,080 | — | — |
| Goodwill | 44,924 | 44,374 | +1.2% |
| Other Non-Current Assets | 3,389 | 3,180 | +6.6% |
| Total Assets | 157,919 | 157,639 | +0.2% |
| Other Assets | |||
| Property Plant And Equipment And Finance Lease Right Of Use Asset After Accumulated Depreciation And Amortization | 3,650 | 3,594 | +1.6% |
| Intangible Assets Net Excluding Goodwill | 28,975 | 29,791 | -2.7% |
| Separate Account Asset At Carrying Value | 7,556 | — | — |
| Separate Account Assets | 7,533 | 7,651 | -1.5% |
Show Fair Value Hierarchy breakouts |
|||
| Fair Value Inputs Level1 | 522 | — | — |
| Fair Value Inputs Level1 · Separate Account, Guaranteed Separate Accounts | 248 | — | — |
| Fair Value Inputs Level1 · Separate Account, Non-Guaranteed Separate Accounts | 274 | — | — |
| Fair Value Inputs Level12 And3 | 6,877 | — | — |
| Fair Value Inputs Level12 And3 · Separate Account, Guaranteed Separate Accounts | 581 | — | — |
| Fair Value Inputs Level12 And3 · Separate Account, Non-Guaranteed Separate Accounts | 6,296 | — | — |
| Fair Value Inputs Level2 | 6,142 | — | — |
| Fair Value Inputs Level2 · Separate Account, Guaranteed Separate Accounts | 333 | — | — |
| Fair Value Inputs Level2 · Separate Account, Non-Guaranteed Separate Accounts | 5,809 | — | — |
| Fair Value Inputs Level3 | 213 | — | — |
| Fair Value Inputs Level3 · Pension Plans Defined Benefit | 0.2 | — | — |
| Fair Value Inputs Level3 · Separate Account, Non-Guaranteed Separate Accounts | 213 | — | — |
| Fair Value Measured At Net Asset Value Per Share | 656 | — | — |
Show Retirement Plan Type breakouts |
|||
| Pension Plans Defined Benefit · Separate Account, Non-Guaranteed Separate Accounts | 3.8 | — | — |
| Current Liabilities | |||
| Insurance And Contractholder Liabilities Current | 6,018 | — | — |
| Accounts Payable | 9,346 | 8,515 | +9.8% |
| Debt Current | 3,093 | — | — |
| Total Current Liabilities | 56,453 | 57,060 | -1.1% |
| Non-Current Liabilities | |||
| Insurance And Contractholder Liabilities Noncurrent | 10,079 | — | — |
| Deferred Tax Liabilities | 6,997 | 6,794 | +3.0% |
| Other Non-Current Liabilities | 3,873 | 3,033 | +27.7% |
| Total Liabilities | 115,905 | 115,341 | +0.5% |
| Other Liabilities | |||
| Pharmacy And Service Costs Payable | 30,301 | 28,801 | +5.2% |
| Accrued Expenses And Other Liabilities | 7,695 | 8,920 | -13.7% |
| Long Term Debt And Capital Lease Obligations | 30,947 | — | — |
| Separate Accounts Liability | 7,556 | 7,651 | -1.2% |
| Stockholders' Equity | |||
| Common Stock | 4 | 4 | 0.0% |
| Additional Paid In Capital Common Stock | 31,698 | 31,186 | +1.6% |
| Accumulated Other Comprehensive Income | -2,799 | -2,163 | -29.4% |
| Retained Earnings | 47,028 | 42,480 | +10.7% |
| Treasury Stock Value | -34,126 | -29,412 | -16.0% |
| Total Stockholders' Equity | 41,805 | 42,095 | -0.7% |
| Minority Interest | 209 | 203 | +3.0% |
| Stockholders Equity Including Portion Attributable To Noncontrolling Interest | 42,014 | 42,298 | -0.7% |
Show Equity Components breakouts |
|||
| Accumulated Defined Benefit Plans Adjustment | -927 | -915 | -1.3% |
| Accumulated Other Comprehensive Income | -2,799 | -2,163 | -29.4% |
| Accumulated Translation Adjustment | -130 | -141 | +7.8% |
| Additional Paid In Capital | 31,698 | 31,186 | +1.6% |
| Common Stock | 4 | 4 | 0.0% |
| Net long-duration insurance and contractholder liabilities measurement adjustments | -2,394 | -1,771 | -35.2% |
| Noncontrolling Interest | 209 | 203 | +3.0% |
| Parent | 41,805 | 42,095 | -0.7% |
| Retained Earnings | 47,028 | 42,480 | +10.7% |
| Securities and derivatives | 652 | 664 | -1.8% |
| Treasury Stock Common | -34,126 | -29,412 | -16.0% |
| Total Liabilities & Equity | 157,919 | 157,639 | +0.2% |
Cash Flow Statement
| Metric | YTD Q3 2025 | YTD Q3 2024 | YoY |
|---|---|---|---|
| Operating Activities | |||
| Depreciation & Amortization | 2,053 | 2,129 | -3.6% |
Show Business Segments breakouts |
|||
| All Other Segments · Operating Segments | 13 | 7 | +85.7% |
| Cigna Healthcare · Operating Segments | 252 | 334 | -24.6% |
| Evernorth Health Services · Operating Segments | 1,772 | 1,764 | +0.5% |
Show Consolidation Items breakouts |
|||
| Corporate and Eliminations | 16 | 24 | -33.3% |
| Increase Decrease In Deferred Income Taxes | -174 | -351 | +50.4% |
| Increase Decrease In Accounts And Other Receivables | -6,911 | -10,600 | +34.8% |
| Change in Inventory | 1,060 | 577 | +83.7% |
| Increase Decrease In Reinsurance Recoverable | -537 | -358 | -50.0% |
| Increase Decrease In Insurance Liabilities | 1,662 | -214 | +876.6% |
| Increase Decrease In Pharmacy And Service Costs Payable | 1,837 | 8,979 | -79.5% |
| Increase Decrease In Accounts Payable Accrued And Other Operating Liabilities | -857 | -819 | -4.6% |
| Increase Decrease In Other Operating Capital Net | 460 | 655 | -29.8% |
| Net Cash from Operations | 3,452 | 5,151 | -33.0% |
| Investing Activities | |||
| Proceeds From Sale Of Debt And Equity Securities | 518 | 569 | -9.0% |
| Proceeds From Maturities Prepayments And Calls Of Debt And Equity Securities | 745 | 585 | +27.4% |
| Proceeds From Collection Of Loans Receivable | 198 | 79 | +150.6% |
| Proceeds From Sale And Maturity Of Other Investments | 656 | 567 | +15.7% |
| Payments To Acquire Debt And Equity Securities | -5,271 | -943 | -459.0% |
| Payments To Acquire Mortgage Notes Receivable | -117 | -54 | -116.7% |
| Payments To Acquire Other Investments | -1,066 | -1,028 | -3.7% |
| Payments For Proceeds From Property Plant And Equipment | -890 | -1,069 | +16.7% |
| Payments To Acquire Businesses Net Of Cash Acquired | -597 | -132 | -352.3% |
| Proceeds From Divestiture Of Businesses Net Of Cash Divested | 2,346 | — | — |
| Payments To Acquire Equity Method Investments | -485 | -466 | -4.1% |
| Other Investing Activities | -24 | -19 | -26.3% |
| Net Cash from Investing | -3,987 | -1,911 | -108.6% |
| Financing Activities | |||
| Additions To Contract Holders Funds | 113 | 120 | -5.8% |
| Withdrawal From Contract Holders Funds | -201 | -180 | -11.7% |
| Proceeds From Repayments Of Other Short Term Debt | -915 | 366 | -350.0% |
| Proceeds From Notes Payable | 1,999 | — | — |
| Repayments Of Notes Payable | -2,000 | — | — |
| Repayments Of Long Term Debt | -1,643 | -3,000 | +45.2% |
Show Debt Instrument breakouts |
|||
| $900 million, 3.25% Notes Due 2025 · Senior Notes | -900 | — | — |
| Proceeds From Issuance Of Long Term Debt | 4,461 | 4,462 | -0.0% |
| Share Repurchases | -2,620 | -5,012 | +47.7% |
| Proceeds From Issuance Of Common Stock | 178 | 283 | -37.1% |
| Payments Of Dividends Common Stock | -1,215 | -1,183 | -2.7% |
| Proceeds From Payments For Other Financing Activities | -512 | -255 | -100.8% |
| Net Cash from Financing | -2,355 | -4,399 | +46.5% |
| Supplemental | |||
| Income Taxes Paid | 356 | 839 | -57.6% |
| Interest Paid | 1,043 | 1,037 | +0.6% |
| Other Cash Flow | |||
| Effect Of Exchange Rate On Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations | 30 | 6 | +400.0% |
| Net Change in Cash | -2,860 | -1,153 | -148.0% |
| Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations | 6,071 | 7,184 | -15.5% |
| Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents | 6,071 | 5,935 | +2.3% |
Values in millions USD. Source: SEC EDGAR 10-Q filing.